PNC Financial Services Group
NWBO

PNC Financial Services Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

PNC Financial Services Group’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,708
Closed -$2K – 4258
2016
Q3 		$2K Hold
3,708
– – ﹤0.01% 3871
2016
Q2 		$2K Hold
3,708
– – ﹤0.01% 4319
2016
Q1 		$5K Hold
3,708
– – ﹤0.01% 3892
2015
Q4 		$12K Sell
3,708
-58
-2% -$279 ﹤0.01% 3549
2015
Q3 		$24K Buy
3,766
+58
+2% +$542 ﹤0.01% 3295
2015
Q2 		$37K Hold
3,708
– – ﹤0.01% 3203
2015
Q1 		$27K Hold
3,708
– – ﹤0.01% 3369
2014
Q4 		$20K Buy
+3,708
New +$19K ﹤0.01% 3165

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

PNC Financial Services Group's NWBO Position: Q4 2016 in Review

PNC Financial Services Group sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 3,708 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in NWBO in Q4 2014 and held it in 8 quarters. The position peaked at $37K in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • PNC Financial Services Group reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 3,708 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $2K.
  • PNC Financial Services Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2014 and held it in 8 quarters.
  • PNC Financial Services Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $37K in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on PNC Financial Services Group's 13F filing for Q4 2016, filed 10 Feb 2017.